<DOC>
	<DOCNO>NCT03020537</DOCNO>
	<brief_summary>In exploratory study , investigator look immune response difference age group two different vaccine give identical twin vaccine-naive young adult .</brief_summary>
	<brief_title>B-cell Immunity Influenza ( SLVP017 ) - Year 5 , 2013</brief_title>
	<detailed_description>This study healthy child adult give standard seasonal influenza vaccination ( IIV3 ) . There exclusion gender , ethnicity race . Following review confirmation write informed consent , volunteer enrol study . The 1-2 year-old child volunteer enrol Group A previously immunized influenza vaccine . They receive two single dos 2013-2014 pediatric formulation seasonal trivalent inactivate influenza vaccine ( IIV3 ) , least 28 day apart , give intramuscular ( IM ) injection . The child volunteer complete 4 clinic visit 3 blood sample collection . Study visit Day 0 ( first immunization ) , Day 28-32 ( second immunization ) , Day 6-8 post-Dose 2 , Day 28+4 post-Dose 2 . The baseline blood sample drawn prior immunization Day 0 , follow two additional blood sample Day 6-8 post-Dose 2 , Day 28+4 post-Dose 2 . There blood sample collect Day 28-32 . The 18-30 year-old young adult Group B immunize 2012-2013 seasonal influenza vaccine . Participants Group B receive single dose 2013-2014 IIV3 IM injection . Young adult volunteer complete 3 clinic visit 3 blood sample collection Day 0 , Day 6-8 , Day 28+4 . The baseline blood sample drawn prior immunization Day 0 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy , ambulatory child 12 year age 1830 yearold young adult . 2 . Willing complete informed consent process . 3 . Availability followup plan duration study ( last study immunization , approximately 8 week Group A 4 week Group B ) . 4 . Acceptable medical history medical history vital sign . 1 . Group A : Prior vaccination seasonal flu vaccine ( IIV ) . Group B : Prior vaccination 20122013 seasonal flu vaccine ( IIV LAIV ) . 2 . Prior offstudy vaccination current 20132014 seasonal IIV LAIV 3 . Allergy egg egg product , vaccine component . 4 . Lifethreatening reaction previous influenza vaccination 5 . Active systemic serious concurrent illness , include febrile illness day vaccination 6 . History immunodeficiency ( include HIV infection ) 7 . Known suspected impairment immunologic function , include , limited , clinically significant liver disease , diabetes mellitus treat insulin , moderate severe renal disease , chronic disorder , opinion investigator , might jeopardize volunteer safety compliance protocol . 8 . Chronic Hepatitis B C. 9 . Recent current use immunosuppressive medication , include systemic glucocorticoid ( corticosteroid nasal spray topical steroid permissible ; use inhale steroid , oral steroid ( &lt; 20mg prednisoneequivalent/day ) , may acceptable review investigator . 10 . Malignancy , squamous cell basal cell skin cancer ( include solid tumor breast cancer prostate cancer recurrence past year , hematologic cancer leukemia ) . 11 . Autoimmune disease ( include rheumatoid arthritis ) treat immunosuppressive medication Plaquenil , methotrexate , prednisone , Enbrel ) , opinion investigator , might jeopardize volunteer safety compliance protocol . 12 . History blood dyscrasia , renal disease , hemoglobinopathies require regular medical follow hospitalization precede year 13 . Use anticoagulation medication Coumadin Lovenox , antiplatelet agent aspirin ( except 325 mg. per day ) , Plavix , Aggrenox must review investigator determine would affect volunteer 's safety . 14 . Receipt blood blood product within past 6 month 15 . Medical psychiatric condition occupational responsibility preclude participant compliance protocol 16 . Inactivated vaccine within 14 day prior study vaccination ( inform study staff nonstudy vaccination receive study period ) 17 . Live , attenuate vaccine within 30 day prior first study vaccination , plan immunization live , attenuate vaccine completion study visit ( inform study staff nonstudy vaccination receive study period ) . 18 . Need allergy immunization ( rescheduled necessary ) study period 19 . History GuillainBarre Syndrome 20 . Pregnant lactate woman 21 . Use investigational agent within 30 day prior enrollment plan use investigational agent prior completion study visit 22 . Donation equivalent unit blood within 6 week prior enrollment 23 . Any condition , opinion investigator , might interfere volunteer safety , study objective ability participant understand comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Trivalent inactivate influenza vaccine</keyword>
	<keyword>Young child</keyword>
	<keyword>Young adult</keyword>
</DOC>